Research ArticleParkinson’s Disease

LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits

See allHide authors and affiliations

Science Translational Medicine  22 Apr 2020:
Vol. 12, Issue 540, eaav0820
DOI: 10.1126/scitranslmed.aav0820

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article